ghk-cu peptide 50mg (50mg Unit) GHK-CU - 50mg

Pharmacokinetic characterization of angiotensin IV analogs with therapeutic potential for cancer and dementia

We built this company on a foundation of absolute transparency, rigorous scientific standards, and actual customer respect

Discovered in 1973, this tripeptide has accumulated over 40 years of research demonstrating its regenerative properties

The antioxidant properties of GHK were assessed using two primary techniques: flow cytometry, a method for analyzing various cellular characteristics, and electron spin resonance (ESR) spin-trapping, which is employed to detect free radicals

The testing should come from an independent laboratory, not the manufacturers in-house facility